📋 FDA Reference

Bard Utraverse Small Vessel PTA Balloon Dilatation Catheter

C. R. Bard, Inc.

Contact C. R. Bard, Inc. ↗ Compare similar devices

Summary: The Bard Utraverse Small Vessel PTA Balloon is a medical device used for percutaneous transluminal angioplasty (PTA) in small vessels. It is primarily used by interventional radiologists and vascular surgeons to treat peripheral artery disease.

FDA Clearance Information

Pathway ? 510(k)
Number ? K010169 ↗
Decision Date ? February 13, 2001
Product Code ? DQY Catheter, Percutaneous
Device Class ? Class 2
Evidence ? 0 studies

The Bard Utraverse Small Vessel PTA Balloon was cleared through the FDA 510(k) pathway on February 13, 2001. Manufactured by C.R. Bard, it is classified as a Class 2 medical device under product code DQY.

What It Is

The Bard Utraverse Small Vessel PTA Balloon is a catheter-based device designed for the dilation of small vessels. It works by inflating a balloon within the vessel to open up blockages and improve blood flow. This device is particularly useful in treating peripheral artery disease (PAD), where it helps to restore perfusion in narrowed or blocked arteries.

FDA-Cleared Indications

  • Use in percutaneous transluminal angioplasty of peripheral small vessels.
  • Dilation of stenotic or obstructed peripheral arteries to improve blood flow.
  • Use during endovascular treatment of peripheral vascular disease when balloon angioplasty is indicated.

Clinical Applications

  • Balloon angioplasty of narrowed small peripheral arteries.
  • Endovascular treatment of peripheral arterial stenosis or occlusion.
  • Treatment of lower-extremity peripheral artery disease when the target vessel is appropriate for the catheter's size range.
  • Adjunctive balloon dilation during a peripheral vascular intervention.

Reported off-label uses

  • Use in selected venous angioplasty procedures, such as treatment of focal venous stenosis, may occur in clinical practice but is not necessarily covered by the device's small-vessel arterial labeling.
  • Use in vessels or clinical situations outside the labeled size, anatomy, or indication may be considered off-label and should be based on clinician judgment, available evidence, and institutional policy.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Practical Considerations

  • Select the balloon diameter and length to match the target vessel and follow the product labeling for rated burst pressure and inflation technique.
  • The catheter is used over a compatible guidewire under fluoroscopic or other appropriate imaging guidance, generally through percutaneous arterial access.
  • Do not use if the device is damaged, expired, or incompatible with the planned guidewire, sheath, contrast medium, or inflation system.
  • MRI safety depends on the specific catheter and whether any device components remain in the patient; confirm the current labeling before MRI.
  • Potential complications include vessel dissection, perforation, thrombosis, embolization, bleeding, restenosis, and allergic or kidney-related complications from contrast.

Related Literature

The linked study, 'Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial,' explored the use of drug-coated balloons in treating peripheral artery disease. The study highlighted the evolution of endovascular therapies and the role of PTA as a standard treatment. While drug-coated balloons showed promise, PTA remains a primary modality. Limitations include the need for more long-term data on outcomes.

Procedures that use this device

Frequently Asked Questions

What is the Bard Utraverse Small Vessel PTA Balloon used for?

It is used for percutaneous transluminal angioplasty to open narrowed or blocked small vessels, particularly in patients with peripheral artery disease.

What specialties typically use this device?

Interventional radiologists and vascular surgeons commonly use this device in endovascular procedures.

What are the FDA-cleared indications?

The device is indicated for use in percutaneous transluminal angioplasty to treat narrowed or blocked small vessels in patients with peripheral artery disease.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you